Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?

Sergio Schwartzman, C. Michael Samson

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Hydroxychloroquine and quinacrine are frequently used to treat rheumatic diseases. Ocular toxicity, although infrequent, is one of the potential side effects of antimalarial therapies. Current recommendations are unifocal in being developed by only ophthalmologists who do not treat patients for their rheumatic diseases. The data used to create the recommendations are meager and retrospective. Comanagement of patients with rheumatic disease who are exposed to antimalarial therapies requires a greater interaction between ophthalmologists and rheumatologists.

Original languageEnglish
Pages (from-to)359-367
Number of pages9
JournalRheumatic Disease Clinics of North America
Volume45
Issue number3
DOIs
StatePublished - Aug 2019
Externally publishedYes

Keywords

  • Antimalarials
  • Hydroxychloroquine
  • Ocular toxicity
  • Quinacrine
  • Retinopathy

Fingerprint

Dive into the research topics of 'Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?'. Together they form a unique fingerprint.

Cite this